Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00358_DB00582_nanopub.RAFsoBFMu44LjGgSR6TsW9KNxbkE_IN9vbsVe7b7LYfh8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00358_DB00582 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00358_DB00582 label "DDI between Mefloquine and Voriconazole - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of mefloquine by decreasing its metabolism. Additive QTc prolongation may also occur. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of mefloquine if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00358_DB00582]" assertion.
- drugbank_resource:DB00358_DB00582 identifier "drugbank_resource:DB00358_DB00582" assertion.
- drugbank_resource:DB00358_DB00582 title "DDI between Mefloquine and Voriconazole - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of mefloquine by decreasing its metabolism. Additive QTc prolongation may also occur. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of mefloquine if voriconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00582 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00358_DB00582 assertion.
- drugbank:DB00358 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00358_DB00582 assertion.